Suppr超能文献

黄连与 COVID-19:抗 COVID-19 化学成分、临床试验、发明和专利文献一览。

L. and COVID-19: A Glance at The Anti-COVID-19 Chemical Constituents, Clinical Trials, Inventions, and Patent Literature.

机构信息

Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Northern Border University, Rafha 91911, Saudi Arabia.

Department of Pharmaceutical Chemistry, College of Pharmacy, National University of Science and Technology, Muscat 130, Oman.

出版信息

Molecules. 2022 Apr 25;27(9):2750. doi: 10.3390/molecules27092750.

Abstract

COVID-19 has had an impact on human quality of life and economics. Scientists have been identifying remedies for its prevention and treatment from all possible sources, including plants. L. (NS) is an important medicinal plant of Islamic value. This review highlights the anti-COVID-19 potential, clinical trials, inventions, and patent literature related to NS and its major chemical constituents, like thymoquinone. The literature was collected from different databases, including Pubmed, Espacenet, and Patentscope. The literature supports the efficacy of NS, NS oil (NSO), and its chemical constituents against COVID-19. The clinical data imply that NS and NSO can prevent and treat COVID-19 patients with a faster recovery rate. Several inventions comprising NS and NSO have been claimed in patent applications to prevent/treat COVID-19. The patent literature cites NS as an immunomodulator, antioxidant, anti-inflammatory, a source of anti-SARS-CoV-2 compounds, and a plant having protective effects on the lungs. The available facts indicate that NS, NSO, and its various compositions have all the attributes to be used as a promising remedy to prevent, manage, and treat COVID-19 among high-risk people as well as for the therapy of COVID-19 patients of all age groups as a monotherapy or a combination therapy. Many compositions of NS in combination with countless medicinal herbs and medicines are still unexplored. Accordingly, the authors foresee a bright scope in developing NS-based anti-COVID-19 composition for clinical use in the future.

摘要

COVID-19 对人类生活质量和经济产生了影响。科学家们一直在从包括植物在内的各种来源寻找预防和治疗 COVID-19 的方法。L.(NS)是一种具有伊斯兰价值的重要药用植物。本综述强调了 NS 及其主要化学成分,如百里醌,在抗 COVID-19 方面的潜力、临床试验、发明和专利文献。文献来自不同的数据库,包括 Pubmed、Espacenet 和 Patentscope。文献支持 NS、NS 油(NSO)及其化学成分对 COVID-19 的疗效。临床数据表明,NS 和 NSO 可以预防和治疗 COVID-19 患者,使其更快康复。几项包含 NS 和 NSO 的发明已在专利申请中声称可预防/治疗 COVID-19。专利文献将 NS 作为免疫调节剂、抗氧化剂、抗炎剂、抗 SARS-CoV-2 化合物的来源以及对肺部具有保护作用的植物引用。现有事实表明,NS、NSO 及其各种成分都具有作为有前途的预防、管理和治疗高危人群 COVID-19 的方法以及作为单一疗法或联合疗法治疗所有年龄段 COVID-19 患者的所有属性。NS 与无数草药和药物的许多组合仍未被探索。因此,作者预计未来开发基于 NS 的抗 COVID-19 组合物用于临床应用的前景光明。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验